Tirzepatide (GIP/GLP-1 Agonists) for Diabetes: Pharmacology Made Easy

Tirzepatide (Mounjaro/Zepbound)—the dual incretin GIP/GLP-1 agonist—is a beneficial treatment of type 2 diabetes and/or obesity.  In this lecture from This is Why, Dr. Busti will break down how tirzepatide works (MOA), why combining GIP + GLP-1 improves A1C reduction and supports weight loss, and where it fits in the treatment of type 2 diabetes. You’ll also get the high-yield points you need for exams and the bedside: tirzepatide dosing basics, common adverse effects, contraindications/precautions, and practical tips for patient counseling (nausea, GI effects, injection technique, and expectations).

You’ll learn how to:
- Tirzepatide overview: Mounjaro vs Zepbound
- GIP/GLP-1 agonist mechanism (dual incretin)
- Clinical use in type 2 diabetes
- A1C lowering + weight loss effects
- Adverse effects, warnings, and counseling pearls

The goal = make medical education easy and clinically relevant.

👉 Access bonus materials and downloads from this episode at: https://www.thisiswhy.health/topics/tirzepatide-mounjaro-zepbound-gip-glp1-agonist-type-2-diabetes-pharmacology

👉 Get more with a free membership at https://www.thisiswhy.health/
- Access free downloads from our videos 
- Access deep dive content from Dr. Busti
- Organize content via playlists & collections
- Join live Q&A
- Receive member newsletters
- Coupons & discounts for exam prep resources

👍 If this helped you, please like, subscribe, and share it with a classmate or colleague. That will help this new channel continue producing free, high-yield medical education content.

🔔 Don’t forget to turn on notifications so you don’t miss upcoming lectures in pharmacology, medical rounds, and more!

#tirzepatide #mounjaro #gipglp1 #type2diabetes #busti

Disclaimer:
This content is for educational purposes only and is not medical advice. It does not replace individualized evaluation, diagnosis, or treatment. Always seek the advice of a qualified health provider with questions about a medical condition and never delay care because of educational content.